Role of the microbiota and antibiotics in primary sclerosing cholangitis

James H. Tabibian, Jayant A. Talwalkar, Keith D. Lindor

Research output: Contribution to journalReview article

48 Citations (Scopus)

Abstract

Primary sclerosing cholangitis (PSC) is an idiopathic, progressive, cholestatic liver disease with considerable morbidity and mortality and no established pharmacotherapy. In addition to the long-recognized association between PSC and inflammatory bowel disease, several lines of preclinical and clinical evidence implicate the microbiota in the etiopathogenesis of PSC. Here we provide a concise review of these data which, taken together, support further investigation of the role of the microbiota and antibiotics in PSC as potential avenues toward elucidating safe and effective pharmacotherapy for patients afflicted by this illness.

Original languageEnglish (US)
Article number389537
JournalBioMed Research International
Volume2013
DOIs
StatePublished - 2013
Externally publishedYes

Fingerprint

Drug therapy
Sclerosing Cholangitis
Microbiota
Anti-Bacterial Agents
Liver
Drug Therapy
Inflammatory Bowel Diseases
Liver Diseases
Morbidity
Mortality

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Immunology and Microbiology(all)

Cite this

Role of the microbiota and antibiotics in primary sclerosing cholangitis. / Tabibian, James H.; Talwalkar, Jayant A.; Lindor, Keith D.

In: BioMed Research International, Vol. 2013, 389537, 2013.

Research output: Contribution to journalReview article

Tabibian, James H. ; Talwalkar, Jayant A. ; Lindor, Keith D. / Role of the microbiota and antibiotics in primary sclerosing cholangitis. In: BioMed Research International. 2013 ; Vol. 2013.
@article{8730c04b3e6a49a3bfe55458dadb0423,
title = "Role of the microbiota and antibiotics in primary sclerosing cholangitis",
abstract = "Primary sclerosing cholangitis (PSC) is an idiopathic, progressive, cholestatic liver disease with considerable morbidity and mortality and no established pharmacotherapy. In addition to the long-recognized association between PSC and inflammatory bowel disease, several lines of preclinical and clinical evidence implicate the microbiota in the etiopathogenesis of PSC. Here we provide a concise review of these data which, taken together, support further investigation of the role of the microbiota and antibiotics in PSC as potential avenues toward elucidating safe and effective pharmacotherapy for patients afflicted by this illness.",
author = "Tabibian, {James H.} and Talwalkar, {Jayant A.} and Lindor, {Keith D.}",
year = "2013",
doi = "10.1155/2013/389537",
language = "English (US)",
volume = "2013",
journal = "BioMed Research International",
issn = "2314-6133",
publisher = "Hindawi Publishing Corporation",

}

TY - JOUR

T1 - Role of the microbiota and antibiotics in primary sclerosing cholangitis

AU - Tabibian, James H.

AU - Talwalkar, Jayant A.

AU - Lindor, Keith D.

PY - 2013

Y1 - 2013

N2 - Primary sclerosing cholangitis (PSC) is an idiopathic, progressive, cholestatic liver disease with considerable morbidity and mortality and no established pharmacotherapy. In addition to the long-recognized association between PSC and inflammatory bowel disease, several lines of preclinical and clinical evidence implicate the microbiota in the etiopathogenesis of PSC. Here we provide a concise review of these data which, taken together, support further investigation of the role of the microbiota and antibiotics in PSC as potential avenues toward elucidating safe and effective pharmacotherapy for patients afflicted by this illness.

AB - Primary sclerosing cholangitis (PSC) is an idiopathic, progressive, cholestatic liver disease with considerable morbidity and mortality and no established pharmacotherapy. In addition to the long-recognized association between PSC and inflammatory bowel disease, several lines of preclinical and clinical evidence implicate the microbiota in the etiopathogenesis of PSC. Here we provide a concise review of these data which, taken together, support further investigation of the role of the microbiota and antibiotics in PSC as potential avenues toward elucidating safe and effective pharmacotherapy for patients afflicted by this illness.

UR - http://www.scopus.com/inward/record.url?scp=84887423367&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84887423367&partnerID=8YFLogxK

U2 - 10.1155/2013/389537

DO - 10.1155/2013/389537

M3 - Review article

C2 - 24232746

AN - SCOPUS:84887423367

VL - 2013

JO - BioMed Research International

JF - BioMed Research International

SN - 2314-6133

M1 - 389537

ER -